Merck KGaA, Darmstadt, Germany, comprises three business sectors: Healthcare (Biopharma, Consumer Health, Allergopharma, Biosimilars), Life Science and Performance Materials.
portfolio includes prescription medicines for the treatment of colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes and thyroid disorders, for instance hyper- or hypothyroidism.
The Consumer Health
range comprises over-the-counter products to relieve muscle, joint and back pain, colds and headaches. In addition, the business offers probiotic nutritional supplements, vitamin C and various products with vitamins, minerals and nutrients that support women’s health during pregnancy, nursing and menopause.
The portfolio of Allergopharma
comprises diagnostics and products used in allergen immunotherapy (AIT).
business develops biosimilars for oncology and inflammatory disorders.
The Life Science
business has a broad product and technology portfolio for the life science industry. Its products and services are used to discover, develop and manufacture drugs of chemical and biotechnological origin as well as in research and application laboratories. Moreover, the business offers analytical systems and test kits for the food and beverage industry.
The product portfolio of Performance Materials
comprises specialty chemicals and functional materials for applications in fields such as consumer electronics, lighting, photovoltaics, printing technology, as well as the coatings, plastics, cosmetics and food industries.